SD Biosensor

SD Biosensor Liabilities

The The Liabilities of SD Biosensor (137310.KS) as of Nov 3, 2026 is 905.85 B KRW. In the previous year, The Liabilities was 956.18 B KRW — a change of -5.26% (lower).

Liabilities

905.85 BKRW

YoY

-5.26%

Last updated:

In 2025, SD Biosensor's total liabilities amounted to 905.85 B KRW, a -5.26% difference from the 956.18 B KRW total liabilities in the previous year.

The SD Biosensor Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
31.80 B KRW
Jan 1, 2020
704.10 B KRW
Jan 1, 2021
801.72 B KRW
Jan 1, 2022
315.14 B KRW
Jan 1, 2023
957.28 B KRW
Jan 1, 2024
956.18 B KRW
Jan 1, 2025
905.85 B KRW
The SD Biosensor Liabilities history
YEARLiabilitiesYoY
905.85 BKRW-5.26%
956.18 BKRW-0.12%
957.28 BKRW+203.76%
315.14 BKRW-60.69%
801.72 BKRW+13.87%
704.10 BKRW+2,113.84%
31.80 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing SD Biosensor's Liabilities

SD Biosensor's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SD Biosensor's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SD Biosensor's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SD Biosensor's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SD Biosensor’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SD Biosensor stock

The Liabilities of SD Biosensor is 905.85 B KRW in 2025.

The Liabilities of SD Biosensor changed from 956.18 B KRW to 905.85 B KRW, representing a -5.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's SD Biosensor historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SD Biosensor

All Key Metrics — SD Biosensor